Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triethylene Glycol SCHEMBL20972932 | 1.00 | MEN1 (0.73) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL28797624 | 0.97 | TSHR (0.71) | MEN1KMT2ATSHRMAPK1THRB | |
| Tetraethylene Glycol SCHEMBL18065765 | 0.88 | MEN1 (0.65) | MEN1KMT2ATSHRMAPK1THRB | |
| Triethylene Glycol SCHEMBL18221838 | 0.88 | MEN1 (0.65) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL27833032 | 0.87 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL29250406 | 0.87 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL27812915 | 0.87 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL29251262 | 0.87 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL29250825 | 0.87 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL5135405 | 0.86 | MEN1 (1.00) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195672-A1 | DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF THERAPEUTICS TO NEURONS | THE JOHNS HOPKINS UNIVERSITY | 2025-06-19 | — | — | US | claimed |
| EP-4504268-A1 | DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF THERAPEUTICS TO NEURONS | The Johns Hopkins University (US) | 2025-02-12 | — | — | EP | claimed |
| CN-119053344-A | Dendrimer compositions for targeted delivery of therapeutic agents to neurons | 约翰霍普金斯大学 | 2024-11-29 | — | — | CN | claimed |
| WO-2023196386-A1 | DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF THERAPEUTICS TO NEURONS | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-10-12 | — | — | WO | claimed |
| US-20260102502-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | UNIV JOHNS HOPKINS (US) | 2026-04-16 | — | — | US | disclosed |
| US-20250367294-A1 | BRANCHED MULTI-FUNCTIONAL MACROMONOMERS AND RELATED POLYMERS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4577246-A1 | DENDRIMER CONJUGATES OF ANTIDEPRESSANT AND ANTIPSYCHOTIC AGENTS AND THEIR METHODS OF USE | The Johns Hopkins University (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-4577245-A1 | DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF PSYCHEDELIC THERAPEUTICS | The Johns Hopkins University (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-4577247-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | The Johns Hopkins University (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025137151-A2 | DENDRIMER COMPOSITIONS FOR THE TREATMENT OF ATHEROSCLEROSIS, OBESITY, AND METABOLIC SYNDROMES | THE JOHNS HOPKINS UNIVERSITY (US) | 2025-06-26 | — | — | WO | disclosed |
| US-20250195672-A1 | DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF THERAPEUTICS TO NEURONS | THE JOHNS HOPKINS UNIVERSITY | 2025-06-19 | — | — | US | disclosed |
| CN-119923278-A | Dendrimer compositions for targeted delivery of fantasy therapeutic agents | 约翰霍普金斯大学 | 2025-05-02 | — | — | CN | disclosed |
| US-11338038-B2 | Branched multi-functional macromonomers and related polymers and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-05-24 | — | — | US | disclosed |
| CN-111263758-A | Branched multifunctional macromers and related polymers and uses thereof | 麻省理工学院 | 2020-06-09 | — | — | CN | disclosed |
| US-20200164086-A1 | FUSOGENIC LIPOSOMES, COMPOSITIONS, KITS AND USE THEREOF FOR TREATING CANCER | Apa-advanced Technologies Ltd. (IL) | 2020-05-28 | — | — | US | disclosed |
| EP-3612161-A1 | FUSOGENIC LIPOSOMES, COMPOSITIONS, KITS AND USE THEREOF FOR TREATING CANCER | APA- Advanced Technologies Ltd. (IL) | 2020-02-26 | — | — | EP | disclosed |
| US-10562863-B2 | Heterobifunctional linker | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2020-02-18 | — | — | US | disclosed |
| CN-110709065-A | Fusogenic liposomes, compositions, kits and uses thereof for treating cancer | APA先进技术有限公司 | 2020-01-17 | — | — | CN | disclosed |
| WO-2018193451-A1 | FUSOGENIC LIPOSOMES, COMPOSITIONS, KITS AND USE THEREOF FOR TREATING CANCER | APA- ADVANCED TECHNOLOGIES LTD. (IL) | 2018-10-25 | — | — | WO | disclosed |
| US-20180086724-A1 | HETEROBIFUNCTIONAL LINKER | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086724-A1 | HETEROBIFUNCTIONAL LINKER | MPI, CYBB, CD2BP2 | MEN1 2533/4885KMT2A 2070/4885TSHR 4081/4885 |
| US-20200164086-A1 | FUSOGENIC LIPOSOMES, COMPOSITIONS, KITS AND USE THEREOF FOR TREATING CANCER | FUS, LIPA, HNRNPLL | MEN1 2564/4885KMT2A 3233/4885TSHR 3206/4885 |
| US-20250367294-A1 | BRANCHED MULTI-FUNCTIONAL MACROMONOMERS AND RELATED POLYMERS AND USES THEREOF | MSN, CAD, NEDD8 | MEN1 7/4885KMT2A 1679/4885TSHR 4783/4885 |
| US-20250195672-A1 | DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF THERAPEUTICS TO NEURONS | GPR119, SLC2A2, SLC2A1 | MEN1 513/4885KMT2A 2116/4885TSHR 1397/4885 |
| US-20260102502-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | CNR1, CNR2, GPR18 | MEN1 4032/4885KMT2A 264/4885TSHR 1425/4885 |
| US-11338038-B2 | Branched multi-functional macromonomers and related polymers and uses thereof | MSN, CAD, NEDD8 | MEN1 7/4885KMT2A 1679/4885TSHR 4783/4885 |
| US-10562863-B2 | Heterobifunctional linker | MPI, CYBB, CD2BP2 | MEN1 2533/4885KMT2A 2070/4885TSHR 4081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.